Cellular phenotyping of tumor microenvironments with a high-plex fluorescent labeling and spectral unmixing approach 9333
Abstract Description Tumor microenvironments are complex and host diverse cell types and interactions. In-depth characterization of these environments requires detecting multiple biomarkers within the same sample, which is limited by traditional fluorescent immunohistochemistry (IHC) due to spectral constraints. Further, many high-plex IHC methods are time-consuming or require multiple imaging rounds. Here we developed a one-step multiplex labeling approach using a cocktail of primary antibody conjugates combined with spectral unmixing, enabling the simultaneous detection of 8 biomarkers and a nuclear counterstain. This streamlined approach offers high-plex biomarker detection within a timeframe similar to traditional single-antibody IHC workflows. Using the EVOS S1000 Spatial Imaging System and quantitative image analysis software, we identified multiple distinct myeloid (CD68+), lymphoid (CD20+, CD4+, FOXP3+, CD8+), and proliferating (Ki67+) cell subpopulations in normal and tumor colon tissue samples and compared their abundance and spatial distribution in relation to tissue architecture markers for smooth muscle actin and pan-cytokeratin. Additionally, we analyzed the cellular composition of a tertiary lymphoid structure in the colon tumor, believed to play a role in the immune response to colorectal cancer. These data highlight the advantages of high-plex biomarker detection for phenotyping complex tumor microenvironments using our streamlined labeling workflow and spectral unmixing approach. Topic Categories Tumor Immunology: Cellular Responses and Tumor Microevironment (TIME)
Authors
- Austin M. Harvey (ORCID: https://orcid.org/0000-0003-0568-3843)
- O. J. Golub
Institutions
- Thermo Fisher Scientific (United States) (US)
Publication Details
- Journal
- The Journal of Immunology
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1093/jimmun/vkaf283.2748
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00